Valuation: Pharmaids Pharmaceuticals Limited

Market Cap 976M 10.2M 8.74M 8.17M 7.48M 14.04M 14.23M 96.58M 37.66M 490M 38.3M 37.46M 1.62B P/E 2024
-14.8x
P/E 2025 -22.5x
Enterprise Value 1.34B 14.05M 12.03M 11.26M 10.31M 19.34M 19.6M 133M 51.88M 675M 52.75M 51.6M 2.23B EV / Sales 2024
12,382,225x
EV / Sales 2025 14,347,129x
Free-Float
25.74%
Yield 2024 *
-
Yield 2025 -
08-12 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
05-29 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-12 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
01-05 Pharmaids Pharmaceuticals Limited Announces Completion of Term of Mopperthy Sudheer as Independent Director and Member of the Audit Committee and Nomination & Remuneration Committee, Effective January 5, 2026 CI
01-02 Pharmaids Pharmaceuticals Limited Appoints Dr. Yogananda Moolemath as Independent Director, Effective January 1, 2026 CI
11-28 Pharmaids Pharmaceuticals appoints P N Vijay as chairman effective December 5, 2025 RE
11-28 Pharmaids Pharmaceuticals Limited Announces Board and Committee Changes CI
11-11 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-09-17 Sourabh Hadimani completed the acquisition of 66.50% stake in Anugraha Chemicals P. Ltd. from Pharmaids Pharmaceuticals Limited. CI
25-08-17 Shankarappa Nagaraja Vinaya Babu completed the acquisition of 7.68% stake in Pharmaids Pharmaceuticals Limited for approximately INR 170 million. CI
25-08-07 Pharmaids Pharmaceuticals Limited Announces Executive Changes, Effective August 7, 2025 CI
25-08-07 Pharmaids Pharmaceuticals Limited Announces Resignation of S Prasad as the Chief Executive Officer Effective August 07, 2025 CI
25-08-07 Pharmaids Pharmaceuticals CEO S Prasad resigns RE
1 day+0.19%
1 week-5.15%
Current month+4.00%
1 month+4.03%
3 months+9.85%
6 months-7.96%
Current year-32.35%
1 week 31.2
Extreme 31.2
34.79
1 month 29.5
Extreme 29.5
36.8
Current year 25.6
Extreme 25.6
50.9
1 year 25.6
Extreme 25.6
66
3 years 25.6
Extreme 25.6
87.46
5 years 10.17
Extreme 10.17
87.46
10 years 2.15
Extreme 2.15
87.46
Manager TitleAgeSince
Director of Finance/CFO - 2022-10-12
Chief Tech/Sci/R&D Officer - 2025-08-06
Compliance Officer - 2024-08-13
Director TitleAgeSince
Director/Board Member - 2022-07-08
Director/Board Member - -
Chairman 75 2025-12-04
Change 5-day change 1-year change 3-year change Capi.($)
+0.19%-5.15%-48.13%-12.34% 11.86M
+0.88%+3.84%+77.96%+129.75% 1,109B
+1.07%+3.11%+51.11%+56.67% 644B
+1.20%+5.64%+26.68%+76.48% 463B
+1.02%+3.67%+43.14%+47.27% 371B
+0.85%+2.97%+24.48%+42.54% 301B
+1.26%+4.54%+2.20%+14.84% 256B
+1.88%+5.14%+48.20%+67.80% 234B
+1.59%+0.87%-12.95%-51.91% 205B
+1.87%+5.78%+23.07%+92.57% 178B
Average +1.06%+2.40%+23.58%+46.37% 376.11B
Weighted average by Cap. +1.06%+3.38%+44.79%+72.24%

Financials

2024 2025
Net sales 151.12 1.58 1.35 1.27 1.16 2.17 2.2 14.96 5.83 75.92 5.93 5.8 251.1 194.47 2.03 1.74 1.63 1.49 2.8 2.84 19.25 7.51 97.69 7.63 7.47 323.13
Net income -79.68M -833K -713K -667K -611K -1.15M -1.16M -7.89M -3.08M -40.03M -3.13M -3.06M -132M -108M -1.13M -965K -903K -826K -1.55M -1.57M -10.67M -4.16M -54.14M -4.23M -4.14M -179M
Net Debt 37.29M 390K 334K 312K 286K 537K 544K 3.69M 1.44M 18.73M 1.46M 1.43M 61.96M 368M 3.85M 3.3M 3.09M 2.82M 5.3M 5.37M 36.45M 14.21M 185M 14.45M 14.14M 612M
Logo Pharmaids Pharmaceuticals Limited
Pharmaids Pharmaceuticals Limited is an India-based suppliers of a range of specialty chemicals, skin care, hospital care and generic products in the areas of orthopedic, neuro and gastro, and other. The Company is engaged in the business of trading and manufacturing of generics, bulk drugs, and intermediaries, and other. The Company operates through Bulk Drugs and Intermediates segment. Its specialty chemicals products include Retinol, DL Alpha Tocopherol, D Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10 and D-Biotin. Its skin care products include Best care hands, Hands Sanitizer, Moisturizing Cream, Skinsure Plus, SkinSure Ultra, Alcohol Gel and Barrier Cream. Its hospital care products include Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen G, Strumen TRIACID, Facein Eco, Facein Power 256, Facein Spray, Sod Hypochlorite, Wipes and PPE. Its generic products include Linzomust, Benfoshine, Duojoint, and other.
Employees
28
Date Price Change Volume
26-08-21 32.24 +0.19% 3,197
26-08-20 ₹32.18 -2.48% 2,485
26-08-19 ₹33.00 +0.03% 1,666
26-08-18 ₹32.99 -1.20% 3,332
26-08-17 ₹33.39 -0.15% 4,647
  1. Stock Market
  2. Stocks
  3. PHARMAID Stock